Mesial temporal lobe epilepsy with hippocampal sclerosis is a long-term seizure disorder that starts in a deep brain area called the mesial temporal lobe. People with mesial temporal lobe epilepsy with hippocampal sclerosis often have focal seizures that may include a rising stomach feeling, déjà vu, fear, or brief staring, and some have convulsions. It often begins in childhood or adolescence and can persist into adulthood. Treatment usually starts with anti-seizure medicines, and many benefit from epilepsy surgery or devices when medicines do not control seizures. The outlook varies, but many people live long lives, and early evaluation helps match the right treatment.
Overview
Mesial temporal lobe epilepsy with hippocampal sclerosisSymptoms
Mesial temporal lobe epilepsy with hippocampal sclerosis causes focal seizures with déjà vu, rising stomach feeling, sudden fear or smells, then brief staring and lip smacking with impaired awareness. Afterward confusion and memory gaps are common; some episodes become convulsions.
Outlook and prognosis
Many living with mesial temporal lobe epilepsy with hippocampal sclerosis can reach good seizure control, especially with the right anti-seizure medicines. If seizures persist, surgery or neurostimulation may help, with many reporting fewer seizures and better memory, mood, and daily function.
Causes and risk factors
Mesial temporal lobe epilepsy with hippocampal sclerosis often follows early brain injury or inflammation: prolonged febrile seizures, encephalitis, birth oxygen deprivation, or head trauma. Genetic susceptibility can raise risk, and autoimmune inflammation or repeated severe seizures may further increase vulnerability.
Genetic influences
Genetics plays a modest role in mesial temporal lobe epilepsy with hippocampal sclerosis. Most cases are not directly inherited, but family history can raise risk slightly. Certain gene variants may influence seizure threshold, response to medicines, and surgical outcomes.
Diagnosis
Diagnosis of mesial temporal lobe epilepsy with hippocampal sclerosis relies on seizure history, exam, and tests. EEG often shows temporal-onset seizures, and brain MRI reveals hippocampal sclerosis. Video-EEG and neuropsychological testing can confirm and guide surgery if medicines fail.
Treatment and drugs
Treatment for mesial temporal lobe epilepsy with hippocampal sclerosis often starts with daily antiseizure medicines, chosen and adjusted to limit seizures and side effects. If seizures continue, options include epilepsy surgery (commonly anterior temporal lobectomy), laser ablation, or neurostimulation. Care usually also covers sleep, stress, mood, and memory support.
Symptoms
In mesial temporal lobe epilepsy with hippocampal sclerosis, many people notice brief, repeat episodes that come in spells rather than constant symptoms. People sometimes describe early symptoms of mesial temporal lobe epilepsy with hippocampal sclerosis as warning sensations, odd memories, or a brief blank spell. These events can affect awareness, memory, or emotions and may leave you tired or foggy afterward. Symptoms vary from person to person and can change over time.
Short, hard-to-explain feelings may come before or be the seizure itself, such as a rising wave in the stomach, dizziness, or a sudden whoosh of fear. They last seconds to a minute and can be a cue to get to a safe place. These are often called auras.
A sudden sense that a moment has happened before, or that a familiar scene feels strangely new. It passes quickly but can be unsettling. In mesial temporal lobe epilepsy with hippocampal sclerosis, this can be part of the seizure spell.
You might smell smoke, perfume, or something burning when nothing is there, or notice a metallic or bitter taste. These brief sensory bursts can be the seizure or the start of one. Keeping track of when they happen can help your care team see patterns.
A rolling, elevator-drop sensation can start in the belly and move up the chest or throat. It often lasts under a minute. Some people learn this is their early warning.
How people usually first notice Mesial temporal lobe epilepsy with hippocampal sclerosis?
Many first notice something is wrong after a sudden, brief “blackout” during an otherwise ordinary moment—time slips, a blank stare, or odd, hard-to-explain sensations like a rising feeling in the stomach, a sudden wave of déjà vu, or a metallic taste. These focal “auras” or brief episodes can progress to convulsions, but for many, the first signs of mesial temporal lobe epilepsy with hippocampal sclerosis are repeated, stereotyped spells of altered awareness, memory lapses, or unusual emotions that last seconds to a couple of minutes. Over time, people or their families recognize a pattern—recurrent, similar events—prompting evaluation for how MTLE with hippocampal sclerosis is first noticed.
Types of Mesial temporal lobe epilepsy with hippocampal sclerosis
Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) has a few recognizable clinical variants, shaped by which side of the brain is involved and whether seizures spread beyond the temporal lobe. Daily life often makes the differences between symptom types clearer. Early symptoms of MTLE-HS can include brief déjà vu, a rising stomach sensation, or sudden fear, but patterns vary depending on left versus right hippocampal involvement. Not everyone will experience every type.
Left-sided MTLE-HS
Seizures often start with a rising sensation, déjà vu, or fear. Language can be briefly affected during or after events, leading to word-finding trouble. Memory for words and stories may be weaker over time.
Right-sided MTLE-HS
Auras can include déjà vu, odd smells, or a sudden wave of emotion. Visual-spatial memory and navigation may be more affected than language. Faces and place recognition can feel less reliable after clusters of seizures.
Bilateral involvement
Seizures can originate from both hippocampi, making control harder. Short-term memory and learning new information are often more impacted. Daily functioning may improve with consistent seizure management and memory strategies.
Focal impaired-awareness
Seizures remain in the temporal lobe and alter awareness. People may stare, fumble with hands, or repeat simple movements for 1–2 minutes. Post-event confusion and fatigue are common.
Focal to bilateral tonic-clonic
Seizures start in the temporal lobe and spread to both sides of the brain. This can lead to stiffening, shaking, and loss of awareness. Injury risk is higher, so safety planning is important.
Medication-responsive
Seizures reduce substantially with anti-seizure medicines. Day-to-day memory and mood often stabilize when seizures are controlled. Side effects can occur, so regular follow-up matters.
Medication-resistant
Seizures persist despite trials of appropriate medicines. Evaluation for surgery, neuromodulation, or dietary therapy is often considered. Keeping track of which type you experience most can help.
What genetics can tell you about symptoms
Some people with mesial temporal lobe epilepsy with hippocampal sclerosis have variants in genes like SCN1A, SCN2A, or SCN1B that affect sodium channels, making neurons fire too easily and triggering focal seizures. These genes can also shape symptoms such as aura type, memory problems, and medication response.
Causes and risk factors
Many cases start after an early brain injury or a long fever-related seizure in childhood. Other risk factors for mesial temporal lobe epilepsy with hippocampal sclerosis include lack of oxygen around birth, significant head injury, brain infections, or very prolonged seizures. It is rarely just one factor and the mix matters. A family history of epilepsy or fever-related seizures can raise susceptibility, and certain gene changes may contribute in some people. Sleep loss, high stress, and heavy alcohol use can trigger seizures in people with mesial temporal lobe epilepsy with hippocampal sclerosis, while they do not directly cause the brain scarring.
Environmental and biological risk factors
Understanding what raises risk can help you and your care team plan monitoring and, when possible, prevention. Mesial temporal lobe epilepsy with hippocampal sclerosis often follows an early injury to the memory center of the brain, the hippocampus. Doctors often group risks into internal (biological) and external (environmental). Below are widely recognized environmental and biological risk factors for mesial temporal lobe epilepsy with hippocampal sclerosis.
A very long seizure during a fever (febrile status epilepticus) can injure the hippocampus. This scarring later raises the chance of mesial temporal lobe epilepsy with hippocampal sclerosis. Most brief, simple fever-related seizures are not linked.
Any seizure that goes on for a long time can damage the hippocampus. That injury can leave a scar that makes temporal lobe seizures more likely later on.
Encephalitis or meningitis can inflame and damage the hippocampus. The healing process may leave scars that set the stage for mesial temporal lobe epilepsy with hippocampal sclerosis. A herpes-related brain infection is a classic example.
Lack of oxygen around the time of birth can harm the newborn brain, including the hippocampus. That early hit can evolve into hippocampal sclerosis and later mesial temporal lobe epilepsy.
Genetic risk factors
Genetic factors can raise the chance of developing mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS), but in most people there isn’t a single, clear-cut gene. Genetics does not usually change the early symptoms of mesial temporal lobe epilepsy with hippocampal sclerosis, but it can influence who is more likely to develop it in a family. Research points to both rare, higher-impact variants and many small-effect changes working together. Risk is not destiny—it varies widely between individuals.
Family history: Close relatives with epilepsy or febrile seizures suggest an inherited susceptibility to mesial temporal lobe epilepsy with hippocampal sclerosis. Studies show clustering of temporal lobe seizures and hippocampal sclerosis within some families. This points to shared genes rather than a single cause.
Familial MTLE: Some families have a pattern called familial mesial temporal lobe epilepsy. Many in these families have déjà vu auras and focal seizures, and a subset develop hippocampal sclerosis on scans. The responsible genes appear varied, and testing may not find a single mutation.
Copy-number variants: Rare missing or extra DNA segments, such as 15q13.3, 16p13.11, or 15q11.2, are established genetic risk factors for epilepsy. These changes can predispose to focal epilepsies, including mesial temporal lobe epilepsy with hippocampal sclerosis. A clinical geneticist may consider testing when seizures begin early or other features are present.
mTOR genes: Variants in DEPDC5 and related mTOR pathway genes (NPRL2, NPRL3) cause familial focal epilepsies. In some families, the seizure focus involves the temporal lobe, overlapping with MTLE-HS. Not everyone with these variants develops hippocampal sclerosis.
Ion channel genes: Changes in sodium or GABA receptor genes (for example SCN1A, SCN1B, SCN2A, GABRA1) can increase the likelihood of febrile seizures and focal seizures. Over time, this susceptibility may contribute to mesial temporal seizure networks and, in some, to hippocampal sclerosis. These variants are uncommon but relevant in pediatric-onset cases.
Polygenic background: Beyond rare variants, many common DNA changes each add a small amount of risk. Together, they can tilt susceptibility toward focal epilepsies like MTLE-HS. This helps explain why some relatives are affected while others are not.
Unknown genetic factors: In many people with MTLE-HS, current testing does not pinpoint a cause. This likely reflects risk spread across genes we do not yet routinely test. As research advances, new genes may clarify this hidden heritability.
Lifestyle risk factors
Daily habits can strongly influence seizure control, recovery time after seizures, and medication side effects in mesial temporal lobe epilepsy with hippocampal sclerosis. Understanding lifestyle risk factors for Mesial temporal lobe epilepsy with hippocampal sclerosis can help you choose routines that lower seizure likelihood. Small, consistent changes often add up to better seizure stability and quality of life.
Short or irregular sleep lowers seizure threshold and increases the chance of clusters. A consistent sleep schedule can reduce interictal irritability and help stabilize seizure patterns.
Binge drinking and alcohol withdrawal are common seizure triggers and can be dangerous. Alcohol and recreational stimulants can also interact with antiseizure medicines and impair sleep, raising seizure risk.
Skipping or delaying doses frequently leads to breakthrough seizures. Using reminders and aligning dosing with daily routines can improve seizure control.
Acute and chronic stress can heighten limbic network excitability and precipitate temporal lobe seizures. Stress-reduction skills like breathing, CBT, or mindfulness can reduce seizure frequency.
Risk prevention
Mesial temporal lobe epilepsy with hippocampal sclerosis can’t always be prevented, but you can lower the chance of it developing after severe early-life seizures or brain injuries, and reduce complications if you’re living with it now. Prevention is about lowering risk, not eliminating it completely. Fast treatment of prolonged seizures, good infection prevention, and head injury protection matter most. For many, steady routines and close follow-up also help reduce seizure frequency and protect day-to-day safety.
If a seizure lasts longer than 5 minutes, use prescribed rescue medicine and call emergency services. Treating long seizures quickly may reduce hippocampal damage that can lead to mesial temporal lobe epilepsy with hippocampal sclerosis.
Stay up to date on routine vaccines to reduce brain infections that can scar the temporal lobe. Get urgent care for meningitis, encephalitis, or severe head or neck infections.
Wear a helmet for biking, skiing, or contact sports and use seat belts on every trip. Preventing head injuries lowers the risk of scarring that can contribute to mesial temporal lobe epilepsy with hippocampal sclerosis.
If you have this condition, taking anti-seizure medicine exactly as prescribed helps prevent breakthrough seizures. Consistent dosing also lowers injury and SUDEP risk.
Transmission
Mesial temporal lobe epilepsy with hippocampal sclerosis is not contagious. It cannot be transferred through touch, kissing, sex, coughing, blood, or shared items. The seizures stem from scarring in the hippocampus (a memory area in the brain) that can follow events such as prolonged fever-related seizures in childhood, head injury, a brain infection, or a period of very severe seizures; these are risk factors, not person-to-person transmission.
Most people with mesial temporal lobe epilepsy with hippocampal sclerosis do not inherit it, and there is no single known gene that reliably causes it. Families can have a slightly higher tendency toward seizures, so questions about how mesial temporal lobe epilepsy with hippocampal sclerosis is inherited are common, but when inheritance occurs it is uncommon and not predictable, and this condition is not passed to partners or to a baby during pregnancy the way infections are.
When to test your genes
Consider genetic testing if seizures began in childhood, there’s a family history of epilepsy or sudden unexplained deaths, or your epilepsy is drug‑resistant despite appropriate treatment. Testing can clarify cause, guide anti‑seizure medication choices, and inform surgical planning and prognosis. Discuss timing with your neurologist or a genetic counselor.
Diagnosis
Mesial temporal lobe epilepsy with hippocampal sclerosis often shows up as repeat focal seizures that disrupt daily moments—like a sudden wave of déjà vu, a rising “stomach” feeling, or brief blank stares with lip-smacking and lost time. Doctors usually begin with your story and a careful exam, then add tests to pinpoint where seizures start. The diagnosis of Mesial temporal lobe epilepsy with hippocampal sclerosis typically involves brain imaging and brain-wave testing to confirm the source and rule out other causes.
A clear description of your spells is central to diagnosis. Clues include déjà vu, a rising belly sensation, blank staring, lip-smacking, and confusion after events. Timing, triggers, and how often they occur also help.
Your provider checks memory, language, and attention, plus strength and sensation. Subtle memory or word-finding changes can support a temporal lobe source.
An EEG looks for abnormal electrical activity over the temporal lobe. Video-EEG, done at home or in the hospital, links symptoms on camera with EEG changes to confirm seizure onset.
MRI with an epilepsy protocol looks for hippocampal sclerosis—shrinkage and signal changes in the hippocampus. These imaging findings support how mesial temporal lobe epilepsy with hippocampal sclerosis is diagnosed.
Stages of Mesial temporal lobe epilepsy with hippocampal sclerosis
Mesial temporal lobe epilepsy with hippocampal sclerosis does not have defined progression stages. It usually follows an episodic course—seizures may cluster or go quiet for a time—and day-to-day control is shaped more by treatment and triggers than by a fixed, stepwise decline. Early symptoms of mesial temporal lobe epilepsy with hippocampal sclerosis can include brief déjà vu, a rising feeling in the stomach, an unusual smell or taste, or moments of blank staring, which help your doctor recognize the pattern. Different tests may be suggested to help confirm the diagnosis, including a brain MRI to look for scarring in the hippocampus, an EEG (a brain‑wave test) to check electrical activity, and sometimes memory and language testing to guide care.
Outlook and prognosis
Living with Mesial temporal lobe epilepsy with hippocampal sclerosis can affect school, work, and driving because focal seizures may recur in clusters and recovery time varies. Many people ask, “What does this mean for my future?”, and the answer depends on how often seizures occur, how they respond to anti-seizure medicines, and whether surgery is an option. For some, medicines reduce seizures to rare events; for others, seizures persist despite trying several drugs, which doctors call drug-resistant epilepsy. Everyone’s journey looks a little different.
When thinking about the future, it helps to know that surgery—most commonly removing the scarred hippocampal tissue or using a laser—can lead to long-term seizure freedom in about half to two-thirds of carefully selected adults, especially when early symptoms of Mesial temporal lobe epilepsy with hippocampal sclerosis started on one side and memory on the other side is relatively preserved. If surgery isn’t a fit, neuromodulation devices and optimized medicines can still cut seizure frequency and improve day-to-day safety. Memory and mood issues can accompany this condition; they may stabilize or improve when seizures are better controlled, though some people notice ongoing word-finding or short-term memory challenges. The outlook is not the same for everyone, but seizure reduction typically improves quality of life, independence, and the ability to work or study.
Life expectancy is close to normal for many people with Mesial temporal lobe epilepsy with hippocampal sclerosis, but uncontrolled seizures raise the risk of injuries, status epilepticus, and, rarely, sudden unexpected death in epilepsy (SUDEP). Good seizure control, consistent sleep, medicine adherence, and avoiding known triggers can lower these risks. Understanding the prognosis can guide planning and help you weigh benefits and trade-offs of medicines, surgery, and devices over time. Talk with your doctor about what your personal outlook might look like.
Long-term effects
Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS) often follows a long course shaped by how frequently seizures occur and how they respond to treatment over time. For many, this can mean periods of stability mixed with stretches of breakthrough seizures. Long-term effects vary widely, and they don’t look the same for everyone. Thinking about the long-term effects helps set realistic expectations and plan for safety, memory, mood, and daily life.
Some people continue to have focal seizures for years, especially if medicines don’t fully control them. Even when early symptoms of Mesial temporal lobe epilepsy with hippocampal sclerosis began in childhood, seizures can continue into adulthood. Seizure frequency over time often guides major life decisions.
MTLE-HS is more likely than some other epilepsies to resist multiple medications. This can lead to chronic, unpredictable seizure days. Doctors may track these changes over years to see patterns and risks.
Short-term and episode-based memory can weaken, especially for recent conversations or daily details. Forgetting appointments, misplacing items, or re-asking questions may become more common. The pattern can depend on which side of the brain is affected.
Many notice pauses to retrieve names or common words. Conversations may feel slower or require more effort. Fatigue and recent seizures can make this more noticeable.
How is it to live with Mesial temporal lobe epilepsy with hippocampal sclerosis?
Living with mesial temporal lobe epilepsy with hippocampal sclerosis often means planning your days around uncertainty—seizures can be brief and subtle, like staring spells or déjà vu with a rising stomach sensation, but they can also generalize and leave you exhausted afterward. Memory and attention can be affected between seizures, so many find they rely more on lists, alarms, and structured routines, and they may avoid triggers like sleep loss, alcohol, or high stress. People around you—family, friends, coworkers—often become part of the safety net, learning seizure first aid, helping with transportation if driving restrictions apply, and giving gentle reminders without taking away independence. With a consistent care plan, honest communication, and patience on both sides, most people build a life that feels stable, safer, and more predictable over time.
Treatment and drugs
Treatment for mesial temporal lobe epilepsy with hippocampal sclerosis focuses on controlling seizures and protecting memory, mood, and day-to-day function. Many start with anti-seizure medicines such as levetiracetam, lamotrigine, lacosamide, or others; a doctor may adjust your dose to balance benefits and side effects. If seizures continue despite trying two appropriate medicines, this is often called drug-resistant epilepsy, and surgery to remove or disconnect the seizure focus in the hippocampus or nearby temporal lobe may be considered; for many, temporal lobe surgery offers the best chance of long-term seizure freedom. When surgery isn’t a good fit or seizures persist, devices like vagus nerve stimulation or responsive neurostimulation, and dietary approaches such as a ketogenic or modified Atkins diet, can help reduce seizure frequency. Alongside medical treatment, lifestyle choices play a role, including consistent sleep, limiting alcohol, stress management, and keeping a seizure diary to guide care.
Non-drug treatment
Non-drug care for mesial temporal lobe epilepsy with hippocampal sclerosis focuses on reducing seizures, protecting memory and mood, and improving day-to-day safety. Alongside medicines, non-drug therapies can help many people reach better seizure control or prepare for surgery. Options range from brain-focused procedures that don’t use pills to lifestyle changes and counseling. Your team will tailor choices to your seizure pattern, goals, and what matters most in daily life.
In carefully selected people, removing the scarred hippocampus and nearby tissue can greatly reduce or even stop seizures. This is a planned hospital procedure with testing beforehand to map memory, language, and seizure networks. Recovery is usually measured in weeks, with follow-up rehab as needed.
A thin probe heats and shrinks the scarred area through a small skull opening guided by MRI. Many go home within 1–2 days (about 24–48 hours). It can help when open surgery is not preferred or feasible.
A pacemaker-like device in the chest sends regular pulses to a neck nerve that helps calm seizure activity over time. It can also be swiped with a magnet at the start of auras to potentially shorten events. Benefits often build over months.
A small implant watches for your unique seizure patterns and sends quick pulses to interrupt them. For many living with mesial temporal lobe epilepsy with hippocampal sclerosis, it reduces seizure frequency when surgery isn’t an option. It requires periodic programming adjustments based on recorded data.
Your genes may have an impact on how drugs work for you
Genes can affect how quickly your body processes anti-seizure medicines and how sensitive your brain cells are to them, which can change side effects and dose needs. In mesial temporal lobe epilepsy with hippocampal sclerosis, genetic differences may partly explain why some respond well to certain drugs while others need alternatives.
Pharmacological treatments
For many living with mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE-HS), daily life centers on keeping focal seizures under control so work, school, and driving feel safer. First-line medications are those doctors usually try first, based on safety and how well they control focal seizures. Medicines don’t reverse the scar in the hippocampus, but they can reduce seizures that began after early symptoms of mesial temporal lobe epilepsy. Some people do well on a single drug, while others need a careful combination to reach steady control with manageable side effects.
A common first choice for focal seizures in MTLE-HS, often well tolerated. Possible side effects include rash, dizziness, or headaches.
Frequently used first-line with few drug interactions. It can irritate mood in some people, so report new irritability, anxiety, or depression.
Longstanding option for focal seizures in MTLE-HS. Dizziness, double vision, and low sodium can occur, and it interacts with several medicines.
Similar to carbamazepine with fewer interactions for some. Watch for low sodium, dizziness, or fatigue, especially when starting or increasing dose.
Genetic influences
Genes appear to influence who is more likely to develop mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE‑HS), but the condition is usually not inherited in a simple, single‑gene pattern. Many people with MTLE‑HS have no close relatives with the same diagnosis, though a family history of epilepsy or very long febrile seizures in childhood seems to increase susceptibility. Family history is one of the strongest clues to a genetic influence. In many cases, several small gene changes likely add up and interact with life events—such as prolonged early‑life seizures—to promote scarring in the hippocampus in those who are vulnerable. Rare families show inherited focal epilepsy that can include MTLE‑HS, and even within a family, one person may develop seizures while another has mild or no symptoms. Because a single, definitive gene is uncommon in typical MTLE‑HS, genetic testing is sometimes used to look for broader epilepsy genes or to clarify risk when early symptoms of mesial temporal lobe epilepsy with hippocampal sclerosis appear in childhood; results point to risk and mechanism rather than a guarantee.
Is Mesial temporal lobe epilepsy with hippocampal sclerosis genetic?
Genetics plays a modest role in mesial temporal lobe epilepsy with hippocampal sclerosis. Most cases are not directly inherited, but family history can raise risk slightly. Certain gene variants may influence seizure threshold, response to medicines, and surgical outcomes.
Pharmacogenetics—how genetics influence drug effects
For Mesial temporal lobe epilepsy with hippocampal sclerosis, your genes can influence which seizure medicines are safest and how much you might need. Inherited differences in liver enzymes can change how quickly your body handles medicines like clobazam or phenytoin, which may lead to stronger side effects at standard doses or, for some, not enough benefit. Certain HLA gene types—more common in people with East or Southeast Asian ancestry—greatly raise the risk of rare but severe skin reactions with carbamazepine or oxcarbazepine, and sometimes phenytoin; checking for these before starting treatment can guide a safer choice. These genetic insights don’t predict whether seizures will stop, but they can help tailor dosing and avoid medicines likely to cause harm. Because many living with this condition have drug-resistant seizures, genetics is usually combined with careful follow‑up and, when needed, discussions about surgery or devices rather than used on its own. Ask your doctor if pharmacogenetic testing for Mesial temporal lobe epilepsy with hippocampal sclerosis could help choose a safer starting dose or flag medicines to avoid.
Interactions with other conditions
Many living with this condition also manage mood or sleep problems, which can make seizure control harder. Doctors call it a “comorbidity” when two conditions occur together, and depression, anxiety, migraine, and obstructive sleep apnea are among the most common partners. Poor sleep and untreated sleep apnea can trigger more frequent seizures, while migraine and epilepsy may share similar brain signaling changes that make attacks more likely when the other is active. Because early symptoms of Mesial temporal lobe epilepsy with hippocampal sclerosis can look like panic attacks—sudden fear, a rising feeling in the stomach, déjà vu—some are first treated for anxiety, which can delay the right seizure care. In people with memory disorders such as Alzheimer’s disease, unrecognized temporal lobe seizures may further cloud thinking; bringing seizures under control can sometimes help day-to-day memory. If you also live with diabetes, heart disease, or hormone conditions, medication choices may need adjusting because some anti-seizure drugs can interact with antidepressants, blood thinners, and birth control, so coordinated care is important.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described sudden spells that stole awareness for a moment, followed by confusion or a deep, overwhelming déjà vu. Families and communities once noticed patterns: an aunt who “spaced out” during conversations, a cousin who woke from nightly jolts with a bitten tongue. These lived observations set the stage for what we now recognize as mesial temporal lobe epilepsy with hippocampal sclerosis.
From early theories to modern research, the story of this condition traces the tight link between certain seizure types and the brain’s memory center. Nineteenth‑century clinicians carefully recorded “auras” such as rising stomach sensations, fear, or vivid smells, noting that many people later developed memory difficulties. Early autopsy studies, limited by the tools of their time, sometimes showed scarring and shrinkage deep in the temporal lobes, especially in the hippocampus, a structure crucial for forming new memories. Initially understood only through symptoms, later work connected those symptoms with this specific brain change.
As medical science evolved, electroencephalography (EEG) allowed doctors to spot seizure activity coming from the inner temporal lobe. Surgical teams then correlated EEG findings with tissue changes, confirming that hippocampal sclerosis—scarred, shrunken tissue—often sat at the heart of these seizures. In the late twentieth century, MRI transformed care by revealing the hallmark signs in living people: a smaller, scarred hippocampus on one side, usually matching the side where seizures began. This imaging milestone helped distinguish mesial temporal lobe epilepsy with hippocampal sclerosis from other seizure disorders and guided safer, more targeted surgeries.
Over time, descriptions became more precise. Researchers recognized that some people likely had early-life injuries, infections, prolonged childhood seizures, or febrile status that set the stage for later scarring, while others had no clear trigger. Not every early description was complete, yet together they built the foundation of today’s knowledge. Studies showed that when medicines failed, carefully planned surgery to remove the scarred hippocampus could reduce or stop seizures for many, and long-term follow‑up refined selection criteria and expectations for memory outcomes.
In recent decades, awareness has grown that mesial temporal lobe epilepsy with hippocampal sclerosis is one of the most common forms of focal epilepsy in adults. Modern imaging, neuropsychological testing, and less invasive monitoring have made diagnosis more accurate and treatment more personalized. Today’s research explores why some hippocampi scar while others recover, how networks beyond the hippocampus contribute, and which biomarkers might predict response to therapy. Looking back helps explain why early symptoms of mesial temporal lobe epilepsy with hippocampal sclerosis—brief pauses, déjà vu, fear, or odd smells—were once puzzling, and how careful observation led to the clear, structured care pathways used today.